Moreover, glucose metabolism is significantly decreased in AD patients 10 years before the appearance of clinical symptoms [5], with reductions of Glut-1 and Glut-3 in AD patients’ brains [71, 72]. The gene discussed is SLC2A1; the disease is Alzheimer disease.